Lysergic acid diethylamide modulates hippocampal and cortical local field potential oscillatory rhythms in male mice
B.s. Rabinovitch, N. Silverman, D. Ji, D. Shizgal, E.c. Lewis, P.l. Carlen
Brain Research January 2, 2026 DOI: 10.1016/j.brainres.2025.150142 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Preclinical in vivo electrophysiological study Peer reviewed |
|---|---|
| Population | Male C57BL/6J mice |
| Intervention | Lysergic acid diethylamide (LSD) |
| Dose | 30 µg/kg |
| Topics | LSD |
| Keywords | Hippocampal formation Local field potential Hippocampus Spectral analysis Central nervous system Theta rhythm Electroencephalography |
| Key points | Intraperitoneal administration of 30 µg/kg LSD caused a global decrease in power spectral density in broadband and narrow band oscillatory rhythms of the ventral hippocampus CA1 and CA3 regions, with less robust effects in the somatosensory and medial prefrontal cortices. |
Abstract
Background and rationaleLysergic acid diethylamide (LSD) is a promising therapeutic for psychiatric disorders, but its physiological profile on the nervous system remains elusive. Rodent electrophysiological data has utilized in vivo single-unit electrophysiology recordings, while clinical neurophysiology studies have focused on spectral signatures using electroencephalography (EEG) and magnetoencephalography (MEG). No study to date has examined these spectral signatures in freely-behaving mice. Studying neural activity when an animal is physically restricted (i.e. head-fixed recordings) is stressful to animals, which informed our decision to avoid this confound of additional physical stress on observed effects. Moreover, how LSD acutely modulates intracranial oscillatory rhythms is not known.Experimental approachHere we present the first in vivo electrophysiological investigation of LSD's cortico-hippocampal effects in freely-behaving male C57BL/6J mice using intracranial EEG (iEEG) recordings. We did not posit a hypothesis concerning the specific effects of LSD on power spectral density (PSD) due to the lack of preclinical literature as well as LSD's promiscuous pharmacological profile. This study was purely exploratory.Key resultsFollowing intraperitoneal (IP) administration of 30 µg/kg LSD, there was a global decrease in PSD signal power in both broadband and discrete narrow band oscillatory rhythms of the ventral hippocampus CA1 and CA3 regions. Similar but less robust effects were observed in the somatosensory and medial prefrontal cortices. These data confer with the existing clinical neurophysiology data. Lastly, LSD increased between-subject PSD signal power variance, suggesting individual-specific effects.Conclusion and implicationsOur data lends further credibility to the entropic brain theory of psychedelic drug actions. We conclude that the preclinical intracranial acute spectral signatures of LSD coincide with their clinical counterparts. Further work is needed to study cross-regional connectivity, such as frequency coupling.
Comparable studies
Other preclinical and animal studies on LSD, most cited first.
Citations in the library
Cites 34
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- Trial of Psilocybin versus Escitalopram for Depression New England Journal of Medicine April 14, 2021
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder JAMA Psychiatry November 4, 2020
and 29 more in the library